Among the buyers were Abu Dhabi Investment Authority, BNP Paribas Financial Markets, COPTHALL Mauritius Investment Limited, Ghisallo Master Fund LP, Goldman Sachs (Singapore) PTE, Societe Generale, Morgan Stanley Asia Singapore Fondsen from the Fondsen Fondsen Fondsen Price.
Between them they bought Apollo Hospitals shares worth RS 952 Crore. Eight funds by T. Rowe Price Together bought shares worth RS 327.36 Crore. Societe General was the next top buyer at RS 258 Crore, while the American Ghisallo shoped for shares worth RS 180 Crore. Morgan Stanley Affiliate bought shares worth RS 134 Crore.
BNP Paribas bought shares worth RS 22 Crore, while Abu Dhabi Investment, Copthall and Goldman Sachs each bought shares that amount to RS 10 Crore.
Among domestic entities were Kotak Mahindra Life Insurance Company, Bank of India Mutual Fund, Axis Mutual Fund and Tata Mutual Fund buyers.
The shares were purchased at a price of RS 7,850 each, which had a discount of 1% on the Thursday final race of RS 7,926.50. The shares of Apollo Hospitals closed today flat on RS 7,930.APollo Hospitals Enterprise reported a consolidated net profit of RS 433 Crore in Q1, an increase of 42% compared to RS 305 Crore reported in the period of the year ago. The profit after tax (pat) was due to the owners of the company. Company’s revenue from Operations in the Quarter Grew 15% to RS 5.842 CRORE VS 5.086 CRORE IN Q1FY25. The Pat was 11% HIGHER ON A SEQUENTIAL Basic Versus RS 390 in Q4FY25 While the Topline The By The By The By The By The By The By The By The By The By The By The By The By The By The By The Byreased Inreased in Inreased In Q4FY25. (Disclaimer: Recommendations, Suggestions, Views and Opinions Given by the Experts are their own.
#Apollo #Hospitals #Crore #Block #Deal #attracts #selection #framework #investors #Buy #Rowe #Price #Socgen #Morgan #Stanley #Lead